SEC Form 4 · accession 0001192482-19-000017
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine Henwood
Officer — President and CEO · Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2019 | F | 4,223 | $7.41 | D | 175,008 | D | |
| Common Stock | holding | — | — | — | 50,000 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.